MedPath

ETOP IBCSG Partners Foundation

🇨🇭Switzerland
Ownership
-
Employees
-
Market Cap
-
Website

Liposomal Doxorubicin Compared With Observation or Cyclophosphamide and Methotrexate in Treating Older Women Who Have Undergone Surgery for Breast Cancer

Phase 3
Terminated
Conditions
Breast Cancer
Interventions
First Posted Date
2006-02-24
Last Posted Date
2021-02-23
Lead Sponsor
ETOP IBCSG Partners Foundation
Target Recruit Count
77
Registration Number
NCT00296010
Locations
🇧🇪

Centre Hospitalier Etterbeek Ixelles, Brussels, Belgium

🇧🇪

AZ Groeninge - Oncologisch Centrum, Kortrijk, Belgium

🇧🇪

Institut Jules Bordet, Brussels, Belgium

and more 30 locations

High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Combination Chemotherapy in Treating Women With High-Risk Breast Cancer

Phase 3
Completed
Conditions
Breast Cancer
Interventions
Drug: CMF regimen
Biological: filgrastim
Procedure: peripheral blood stem cell transplantation
Radiation: low-LET electron therapy
Radiation: low-LET photon therapy
First Posted Date
2004-07-29
Last Posted Date
2013-04-04
Lead Sponsor
ETOP IBCSG Partners Foundation
Target Recruit Count
344
Registration Number
NCT00002784
Locations
🇦🇺

Queen Elizabeth Hospital, Adelaide, South Australia, Australia

🇦🇺

Royal Prince Alfred Hospital, Sydney, Sydney, New South Wales, Australia

🇦🇺

Royal Adelaide Hospital, Adelaide, South Australia, Australia

and more 8 locations

Hormone Therapy and Chemotherapy in Treating Perimenopausal or Postmenopausal Women With Node-Positive Breast Cancer

First Posted Date
2004-07-29
Last Posted Date
2013-04-04
Lead Sponsor
ETOP IBCSG Partners Foundation
Target Recruit Count
452
Registration Number
NCT00002529
Locations
🇨🇭

Universitaetsspital, Zurich, Switzerland

🇦🇺

Royal Prince Alfred Hospital, Sydney, Sydney, New South Wales, Australia

🇦🇺

Royal Adelaide Hospital, Adelaide, South Australia, Australia

and more 17 locations

Adjuvant Chemotherapy in Treating Women Who Have Undergone Resection for Relapsed Breast Cancer; Chemotherapy as Adjuvant for LOcally Recurrent Breast Cancer

Phase 3
Completed
Conditions
Breast Cancer
Interventions
Radiation: radiation therapy
Drug: chemotherapy
First Posted Date
2003-12-11
Last Posted Date
2017-06-16
Lead Sponsor
ETOP IBCSG Partners Foundation
Target Recruit Count
162
Registration Number
NCT00074152
Locations
🇺🇸

Hickman Cancer Center at Bixby Medical Center, Adrian, Michigan, United States

🇺🇸

Kaiser Permanente - Deer Valley, Antioch, California, United States

🇺🇸

Kaiser Permanente Medical Center - Hayward, Hayward, California, United States

and more 195 locations

Surgical Resection With or Without Axillary Lymph Node Dissection in Treating Women With Node-Negative Breast Cancer and Sentinel Lymph Node Micrometastases

Not Applicable
Completed
Conditions
Breast Cancer
Interventions
Procedure: Axillary lymph node dissection
Procedure: No axillary lymph node dissection
First Posted Date
2003-11-06
Last Posted Date
2018-01-23
Lead Sponsor
ETOP IBCSG Partners Foundation
Target Recruit Count
931
Registration Number
NCT00072293
Locations
🇮🇹

European Institute of Oncology, Milan, Italy

🇦🇺

Royal North Shore Hospital, St. Leonards, New South Wales, Australia

🇳🇿

Waikato Hospital, Hamilton, New Zealand

and more 28 locations

Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer

Phase 3
Completed
Conditions
Breast Cancer
Interventions
First Posted Date
2003-08-07
Last Posted Date
2025-03-26
Lead Sponsor
ETOP IBCSG Partners Foundation
Target Recruit Count
2672
Registration Number
NCT00066703
Locations
🇺🇸

Elkhart General Hospital, Elkhart, Indiana, United States

🇺🇸

Memorial Hospital of South Bend, South Bend, Indiana, United States

🇺🇸

Greenebaum Cancer Center at University of Maryland Medical Center, Baltimore, Maryland, United States

and more 225 locations

Premenopausal Endocrine Responsive Chemotherapy Trial

Phase 3
Terminated
Conditions
Breast Cancer
Interventions
Drug: chemotherapy
Procedure: oophorectomy
Procedure: ovarian irradiation
First Posted Date
2003-08-07
Last Posted Date
2016-10-28
Lead Sponsor
ETOP IBCSG Partners Foundation
Target Recruit Count
29
Registration Number
NCT00066807
Locations
🇨🇭

Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland

🇨🇭

Kantonsspital - St. Gallen, St. Gallen, Switzerland

🇮🇹

Centro di Riferimento Oncologico - Aviano, Aviano, Italy

and more 3 locations

Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer

Phase 3
Completed
Conditions
Recurrent Breast Carcinoma
Stage IA Breast Cancer
Stage IB Breast Cancer
Stage IIIA Breast Cancer
Estrogen Receptor Positive Breast Cancer
Progesterone Receptor Positive Tumor
Stage IIA Breast Cancer
Stage IIB Breast Cancer
Interventions
Other: Laboratory Biomarker Analysis
Other: Quality-of-Life Assessment
Procedure: Oophorectomy
Radiation: Radiation Therapy
First Posted Date
2003-08-07
Last Posted Date
2025-04-20
Lead Sponsor
ETOP IBCSG Partners Foundation
Target Recruit Count
3066
Registration Number
NCT00066690
Locations
🇺🇸

Charlotte Hungerford Hospital Center for Cancer Care, Torrington, Connecticut, United States

🇺🇸

University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States

🇺🇸

Finley Hospital, Dubuque, Iowa, United States

and more 492 locations

Letrozole or Tamoxifen in Treating Postmenopausal Women With Breast Cancer

Phase 3
Completed
Conditions
Breast Cancer
Interventions
First Posted Date
2003-01-27
Last Posted Date
2017-12-12
Lead Sponsor
ETOP IBCSG Partners Foundation
Target Recruit Count
8028
Registration Number
NCT00004205
Locations
🇩🇰

Rigshospitalet, Copenhagen, Denmark

🇫🇷

Institut Bergonie, Bordeaux, France

🇨🇭

Kantonsspital - St. Gallen, St. Gallen, Switzerland

Surgery With or Without Lymph Node Removal in Treating Older Women With Stage I or Stage IIA Breast Cancer

Phase 3
Completed
Conditions
Breast Cancer
Interventions
Procedure: conventional surgery
Radiation: radiation therapy
Procedure: Axillary clearance
First Posted Date
2003-01-27
Last Posted Date
2013-04-04
Lead Sponsor
ETOP IBCSG Partners Foundation
Target Recruit Count
473
Registration Number
NCT00002528
Locations
🇦🇺

Royal Prince Alfred Hospital, Sydney, Sydney, New South Wales, Australia

🇦🇺

Sir Charles Gairdner Hospital, Perth, Perth, Western Australia, Australia

🇨🇭

Kantonsspital - St. Gallen, St. Gallen, Switzerland

and more 18 locations
© Copyright 2025. All Rights Reserved by MedPath